Abstract:The present study aimed to assess the effect of sigma-1 receptor (S1R) stimulation on autonomic nerve dysfunction and susceptibility to atrial fibrillation (AF) in a rat depression model. Male rats were randomly divided into one of the following four treatment groups: saline [control (CTL)]; saline + intragastric administration of SA4503, an agonist of S1R (CTS); chronic unpredictable mild stress (CUMS) to produce depression (MDD); and CUMS + intragastric administration of SA4503 (MDS). Depression-like behaviors, such as reduced sucrose preference, decreased body weight gain, and increased immobility time during forced swimming, improved in the MDS group after 4 wk of SA4503 treatment. Compared with rats in the CTL group, rats in the MDD group showed significantly augmented sympathetic activity, reduced parasympathetic activity, decreased heart rate variability, and lowered S1R expression in the atrium and hippocampus (all P < 0.01). However, rats in the MDS group showed mitigated aforementioned alterations and improved electrical remodeling compared with rats in the MDD group (all P < 0.01). Furthermore, rats in the MDS group showed shortened activation latencies, increased effective refractory periods, and lowered frequency of AF incidence duration and fibrosis compared with rats in the MDD group (all P < 0.01). The results indicate that S1R stimulation reduces sympathetic activity and susceptibility to AF by improving depressive behaviors, modulating cardiac autonomic nerve balance, lightening nerve remodeling, and upregulating S1R and ion channel protein expression. NEW & NOTEWORTHY Chronic stimulation of the sigma-1 receptor (S1R) ameliorates depression-induced autonomic nerve dysfunction by modulating the imbalance between overactivated sympathetic activity and decreased vagal activity. Chronic S1R stimulation alleviates atrial electrical remodeling, fibrosis, and susceptibility to atrial fibrillation (AF). The S1R agonist may target the underlying mechanisms related to AF occurrence. The results indicate that the S1R could be a potential clinical target for atrial arrhythmia, especially when it is combined with major depressive disorders.

Chronic stimulation of the sigma-1 receptor ameliorates ventricular ionic and structural remodeling in a rodent model of depression

Chronic stimulation of the sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in a rat model of depression

Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats

Effects of Sigma-1 receptor on atrial arrhythmia in depression rat models

Effects of Antidepressant on the Expression of Neuropeptide Y in Brain of a Rat Model of Depression Induced by Chronic Stress

Chronic Inhibition of the Sigma-1 Receptor Exacerbates Atrial Fibrillation Susceptibility in Rats by Promoting Atrial Remodeling.

AP19-00771 Abstract View

P2X7 Receptor Inhibition Prevents Atrial Fibrillation in Rodent Models of Depression.

GW29-e0081 Chronic stimulation of the Sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in rat models of depression

Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.

Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice

Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression

The activation of N-methyl-d-aspartate receptors downregulates transient outward potassium and L-type calcium currents in rat models of depression.

Chronic Sigma 1 Receptor Activation Alleviates Right Ventricular Dysfunction Secondary to Pulmonary Arterial Hypertension.

Mir-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.

Effects of NMDA receptors on cardiac electrophysiological abnormalities in rat with depression after myocardial infarction

Cardiac sensory afferents modulate susceptibility to anxio‐depressive behaviour in a mouse model of chronic heart failure

Corticosteroids Mediate Heart Failure-Induced Depression Through Reduced Σ1-Receptor Expression

Sigma-1 receptor: A potential target for the development of antidepressants

Dilated Virchow–Robin Spaces in the Hippocampus Impact Behaviors and Effects of Anti-Depressant Treatment in Model of Depressed Rats

Fluvoxamine Increased Glutamate Release by Activating Both 5-HT(3) and Sigma-1 Receptors in Prelimbic Cortex of Chronic Restraint Stress C57BL/6 Mice.